RxDoctor Payments Data

Thomas Lee, MD

Pain Medicine · Annapolis, MDNPI 1659357911

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,847 of the $15,242 with a category attached, or 71.2%. 35 manufacturers reported payments, led by Nevro Corp. at 26.6% of the total.

$15,242in general payments, 2019–2025

Across 237 payments — averaging $64.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$4K
  • SPR Therapeutics, Inc$3K
  • Relievant Medsystems, Inc.$2K
  • Boston Scientific$1K
  • Pacira Pharmaceuticals Incorporated$1K
  • Si-bone, Inc.$905
  • plus $3K from 29 others
$132,617in research payments, 2019–2025

Across 13 payments — averaging $10,201 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • SPR Therapeutics, Inc$133K

What the payments were for

  • Travel & lodging$4,39629%
  • Food & beverage$10,84771%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,242 in reported general payments places this provider in the 85th percentile of 144 pain medicine providers in Maryland.

See all pain medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$164,151
Medicare patients
238
Services billed
3,773

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl155$4,765
Pregabalin79$2,347
Gabapentin107$1,454
Celecoxib27$682
Lidocaine15$479
Methylprednisolone49$424
Methocarbamol44$302
Tizanidine Hcl33$148
Prednisone57$123
Meloxicam23$71
Cyclobenzaprine Hcl16$60
Tramadol Hcl32$56
Acetaminophen-CodeineAcetaminophen With Codeine11$50

Paid to pharmacies, not to this prescriber.

Other pain medicine in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →